000959738 000__ 02741nam\a2200601\i\4500 000959738 001__ 959738 000959738 005__ 20210515204637.0 000959738 006__ m\\\\\o\\d\\\\\\\\ 000959738 007__ cr\cn\nnnunnun 000959738 008__ 200721t20212021flua\\\\ob\\\\001\0\eng\d 000959738 010__ $$a 2020025307 000959738 020__ $$a9781003044208$$q(electronic book) 000959738 020__ $$a1003044204$$q(electronic book) 000959738 020__ $$z9780367490485 000959738 020__ $$z9780367608286 000959738 035__ $$a(DLC)EBC6356525 000959738 040__ $$aNhCcYBP$$cNhCcYBP 000959738 042__ $$apcc 000959738 043__ $$an-us--- 000959738 050_4 $$aRM301.27$$b.I58 2021 000959738 08200 $$a615.1072/4$$223 000959738 24500 $$aInterface between regulation and statistics in drug development /$$c[edited by] Demissie Alemayehu, Birol Emir, Michael Gaffney. 000959738 250__ $$aFirst edition. 000959738 264_1 $$aBoca Raton :$$bCRC Press, Taylor & Francis Group,$$c2021. 000959738 264_4 $$c©2021 000959738 300__ $$a1 online resource (xxvi, 146 pages) :$$billustrations. 000959738 336__ $$atext$$btxt$$2rdacontent 000959738 337__ $$acomputer$$bc$$2rdamedia 000959738 338__ $$aonline resource$$bcr$$2rdacarrier 000959738 4901_ $$aChapman & Hall/CRC biostatistics series 000959738 504__ $$aIncludes bibliographical references and index. 000959738 5050_ $$aFundamental principles of clinical trials -- Selected statistical topics of regulatory importance -- Statistical engagement in regulatory interactions -- Emerging topics. 000959738 506__ $$aAccess limited to authorized users 000959738 533__ $$aElectronic reproduction.$$bAnn Arbor, MI$$nAvailable via World Wide Web. 000959738 588__ $$aDescription based on online resource; title from digital title page (viewed on March 01, 2021). 000959738 61010 $$aUnited States.$$bFood and Drug Administration$$xRules and practice. 000959738 650_0 $$aDrugs$$zUnited States$$xTesting$$xStatistical methods. 000959738 650_0 $$aDrugs$$xTesting$$xLaw and legislation$$zUnited States. 000959738 650_0 $$aClinical trials$$zUnited States$$xStatistical methods. 000959738 650_0 $$aClinical trials$$xLaw and legislation$$zUnited States. 000959738 650_0 $$aClinical trials$$xReporting$$zUnited States. 000959738 650_0 $$aDrug development$$zUnited States. 000959738 650_0 $$aPharmaceutical policy$$zUnited States. 000959738 655_7 $$aElectronic books$$2lsch 000959738 7001_ $$aAlemayehu, Demissie,$$eeditor. 000959738 7001_ $$aEmir, Birol,$$eeditor. 000959738 7001_ $$aGaffney, Michael,$$dactive 1983,$$eeditor. 000959738 7102_ $$aProQuest (Firm) 000959738 77608 $$iPrint version:$$tInterface between regulation and statistics in drug development$$bFirst edition.$$dBoca Raton : CRC Press, 2021.$$z9780367490485$$w(DLC) 2020025306 000959738 830_0 $$aChapman & Hall/CRC biostatistics series. 000959738 852__ $$bebk 000959738 85640 $$3GOBI DDA$$uhttps://univsouthin.idm.oclc.org/login?url=https://ebookcentral.proquest.com/lib/usiricelib-ebooks/detail.action?docID=6356525$$zOnline Access 000959738 909CO $$ooai:library.usi.edu:959738$$pGLOBAL_SET 000959738 980__ $$aEBOOK 000959738 980__ $$aBIB 000959738 982__ $$aEbook 000959738 983__ $$aOnline